The accompanying notes are an integral part of
these consolidated financial statements.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Description of Business
Intrusion, Inc. (together with its consolidated
subsidiaries, the “Company,” Intrusion,” “Intrusion Inc.”, “we”, “us”, “our”,
or similar terms) was organized in Texas in September 1983 and reincorporated in Delaware in October 1995. Our principal executive offices
are located at 101 East Park Boulevard, Suite 1200, Plano, Texas 75074, and our telephone number is (972) 234-6400. Our website URL is
www.intrusion.com.
The Company develops, sells, and supports products
that protect any-sized company or government organization by fusing advanced threat intelligence with real-time mitigation to kill cyberattacks
as they occur – including Zero-Days. The Company markets and distributes its solutions through a direct sales force and value-added
resellers. The Company’s end-user customers include U.S. federal government entities, state and local government entities, and companies
ranging in size from mid-market to large enterprises.
TraceCop (“TraceCop™”)
and Savant (“Savant™”) are registered trademarks of Intrusion Inc. The Company has applied
for trademark protection for the Company’s new INTRUSION Shield cybersecurity solution.
2. Summary of Significant Accounting Policies
Basis of Presentation
The Company’s consolidated financial statements
include its accounts and those of its wholly owned subsidiary and are prepared in accordance with Generally Accepted Accounting Principles
in the United States of America (“GAAP”). All intercompany balances and transactions have been eliminated in consolidation.
Going
Concern
As of December 31, 2022, the Company had
cash and cash equivalents of $3.0 million and a working capital deficit of $7.8 million. The Company has incurred net operating losses
in each of the last three years. The Company’s principal sources of cash for funding operations in 2022 was through the issuance
of the two Streeterville notes which contributed $9.3 million, net of issuance costs (see Note 6), and $6.4 million from the sale and
issuance of common stock and warrants. The Streeterville notes have maturities of September 10, and December 29, 2023. These conditions
raise substantial doubt about the ability of the Company to continue as a going concern. Management plans to fund operations of the Company
through additional debt or equity financing. If the Company is not able to obtain additional debt or equity financing on terms and conditions
acceptable to the Company, the Company may be unable to implement the Company’s business plan, fund its liquidity needs or even
continue its operations.
Use of Estimates
The preparation of financial statements in conformity
with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date
of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are used for, but
not limited to, the accounting for doubtful accounts, sales discounts, sales returns, revenue recognition, warranty costs, depreciation,
income taxes and stock-based compensation. Actual results could differ from these estimates.
Cash and Cash Equivalents
The Company considers all highly liquid investments
with an original maturity of three months or less to be cash equivalents. The Company maintains cash balances that may at times exceed
federally insured limits. The Company’s cash balances are maintained at a high-quality financial institution, and the Company believes
the credit risk related to these cash balances is minimal. As of December 31, 2022, and 2021, the Company had approximately $3.0 and $4.1
million, respectively, of cash and cash equivalents.
Accounts Receivable and Allowance for Doubtful
Accounts
Trade accounts receivable are stated at the amount
the Company expects to collect. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability
of its customers to make required payments. Management considers the following factors when determining the collectability of specific
customer accounts: customer creditworthiness, past transaction history with the customer, current economic industry trends, and changes
in customer payment terms. If the financial condition of the Company’s customers were to deteriorate, adversely affecting their
ability to make payments, additional allowances would be required. Based on management’s assessment, the Company provides for estimated
uncollectible amounts through a charge to earnings and an increase to a valuation allowance. Balances that remain outstanding after the
Company has used reasonable collection efforts are written off through a charge to the valuation allowance.
The Company’s accounts receivable
represents unconditional contract billings for sales per contracts with customers and are classified as current. As of December 31,
2022, and 2021, and January 1, 2021, the Company had accounts receivable balances of $0.5, $1.0
and $1.2 million, respectively. The Company did not
recognize an allowance for doubtful accounts as of December 31, 2022, and 2021.
Risk Concentration
Financial instruments, which potentially subject
the Company to concentrations of credit risk, consists primarily of cash and cash equivalents, investments, and accounts receivable. Cash
and cash equivalent deposits are at risk to the extent that they exceed Federal Deposit Insurance Corporation insured amounts. To minimize
risk, the Company places its investments in U.S. government obligations, corporate securities, and money market funds. Substantially all
the Company’s cash, cash equivalents and investments are maintained with one major U.S. financial institution. The Company does
not believe that it is subject to any unusual financial risk with the Company’s banking arrangements. The Company has not experienced
any significant losses on its cash and cash equivalents.
The Company sells its products to customers primarily
in the U.S. In the future, the Company may sell the Company’s products internationally. Fluctuations in currency exchange rates
and adverse economic developments in foreign countries could adversely affect the Company’s operating results. The Company performs
ongoing credit evaluations of its customers’ financial condition and generally require no collateral. The Company maintains reserves
for potential credit losses, and such losses, in the aggregate, have historically been minimal.
The Company’s operations are concentrated
in one area - security software/entity identification. Sales to the U.S. Government through direct and indirect channels totaled 65.8%
of total revenues attributable to seven government customers and 71.4% of total revenues attributable to seven government customers for
the years ended December 31, 2022, and 2021, respectively. Three individual government customers and two individual commercial customers
during the year ended December 31, 2022, individually accounted for over 10% of total revenues and during the year ended December 31,
2021, three government customers and one commercial, individually accounted for over 10% of total revenues. The Company’s similar
product and service offerings are not viewed as individual segments, as the Company’s management analyzes the business as a whole
and expenses are not allocated to each product offering.
Prepaid Expenses and Other Assets
The Company’s prepaid expenses and other
assets balance is primarily related to prepaid insurance, prepaid software, and other subscription services, which represents the unamortized
balance of insurance premiums, or other prepaid services and products. These payments are amortized on a straight-line basis over the
policy or service term.
Property and Equipment
Equipment, furniture, and fixtures are stated
at cost less accumulated depreciation and depreciated on a straight-line basis over the estimated useful lives of the assets. Such lives
vary from 1 to 5 years. Leasehold improvements are stated at cost less accumulated amortization and are amortized on a straight-line basis
over the shorter of estimated useful lives of the assets or the remaining terms of the leases. Such lives vary from 2 to 5 years. Expenditures
for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Repair and maintenance costs
are expensed as incurred.
During 2022, the Company began the capitalization
of internally developed software due to implementing the Agile software development methodology which allowed the Company to accurately
track, and record costs associated with new software development and enhancements.
Pursuant to ASC Topic 350-40 Internal Use Software
Accounting Capitalization, certain development costs related to the Company’s products during the application development stage
are capitalized as part of property and equipment. Costs incurred in the preliminary stages of development are expensed as incurred. The
preliminary stage includes such activities as conceptual formulation of alternatives, evaluation of alternatives, determination of existence
of needed technology, and the final selection of alternatives. Once the application development stage is reached, internal and external
costs are capitalized until the software is complete and ready for its intended use. Capitalized internal use software is amortized on
a straight-line basis over its estimated useful life, which is generally three years.
Depreciation and amortization are recorded as
operating expenses in the Consolidated Statement of Operations. Depreciation and amortization related to the Company’s property
and equipment balances totaled approximately $0.6 million and $0.5 million for the years ended December 31, 2022, and 2021, respectively.
Long-Lived Assets
The Company reviews long-lived assets, including
property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not
be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future
undiscounted cash flows to be generated by the asset. If the carrying value exceeds the future undiscounted cash flows, the assets are
written down to fair value. During the years ended December 31, 2022, and 2021, there was no impairment of long-lived assets.
Leases
The Company accounts for leases using the guidance
in FASB ASC 842. The Company evaluates new contracts at inception to determine if the contract conveys the right to control the use of
an identified asset for a period in exchange for periodic payments. A lease exists if the Company obtains substantially all the economic
benefits of an asset, and the Company has the right to direct the use of that asset. When a lease exists, the Company records a right-of-use
asset that represents its right to use the asset over the lease term and a lease liability that represents its obligation to make payments
over the lease term. Lease liabilities are recorded at the sum of future lease payments discounted by the collateralized rate the Company
could obtain to lease a similar asset over a similar period, and right-of-use assets are recorded equal to the corresponding lease liability,
plus any prepaid or direct costs. The Company does not recognize leases with initial terms of 12 months or less.
Commitments and Contingencies
Liabilities for loss contingencies arising from
claims, assessments, litigation, fines and penalties, or other sources are recorded when it is probable that a liability has been incurred
and the amount of the assessment can be reasonable estimated. The Company is involved in various lawsuits, claims and administrative proceedings
arising in the normal course of business. For additional information, see Note 7 – Commitments and Contingencies.
Foreign Currency
All assets and liabilities in the balance sheets
of foreign subsidiaries whose functional currency is other than the U.S. dollar are translated at year-end exchange rates. All revenues
and expenses in the statement of operations of these foreign subsidiaries are translated at average exchange rates for the year. Translation
gains and losses are not included in determining net income but are shown in accumulated other comprehensive loss in the stockholders’
deficit section of the consolidated balance sheet. Foreign currency transaction gains and losses are included in determining net loss
and were not significant.
Fair Value of Financial Instruments
The Company calculates the fair value of its assets
and liabilities which qualify as financial instruments and include additional information in the notes to consolidated financial statements
when the fair value is different than the carrying value of these financial instruments. The estimated fair value of accounts receivable,
accounts payable and accrued expenses approximate their carrying amounts due to the relatively short maturity of these instruments. Notes
payable and financing and operating leases approximate fair value as they bear market rates of interest. None of these instruments are
held for trading purposes.
Revenue Recognition
The Company recognizes product revenue upon shipment
or after meeting certain performance obligations. These products can include hardware, software subscriptions and consulting services.
Most of the Company’s sales are from consulting services. The Company also offers software on a subscription basis subject to software
as a service (”SaaS”). Warranty costs and sales returns have not been material.
The Company recognize sales of its consulting
services in accordance with FASB ASC Topic 606 whereby revenue from contracts with customers are recognized once the criteria under the
five steps below are met:
|
i) |
identification of the contract with a customer; |
|
|
|
|
ii) |
identification of the performance obligations in the contract; |
|
|
|
|
iii) |
determination of the transaction price; |
|
|
|
|
iv) |
allocation of the transaction price to the separate performance obligations; and |
|
|
|
|
v) |
Recognition of revenue upon satisfaction of a performance obligation. |
Consulting services generally include reporting
and are typically done monthly, and revenue is matched accordingly. Product sales may include maintenance and customer support allocated
revenue in an arrangement using estimated selling prices of the delivered goods and services based on a selling price hierarchy using
the relative selling price method. All product offering and service offering market values are readily determined based on current and
prior stand-alone sales. The Company defers and recognize maintenance, updates, and support revenue over the term of the contract period,
which is generally one year.
Normal payment terms offered to customers, distributors
and resellers are net 30 days domestically. The Company does not offer payment terms that extend beyond one year and rarely does it extend
payment terms beyond its normal terms. If certain customers do not meet its credit standards, the Company does require payments in advance
to limit its credit exposure.
Shipping and handling costs are billed to the
customer and included in revenue. Shipping and handling expenses are included in cost of revenue. The Company has elected to account for
shipping and handling costs as fulfillment costs after the customer obtains control of the goods.
With the Company’s newest product, INTRUSION
Shield, the Company began offering software on a subscription basis. INTRUSION Shield is a hosted arrangement
subject to software as a service guidance under ASC 606. SaaS arrangements are accounted for as subscription services, not arrangements
that transfer a license of intellectual property.
The Company utilizes the five-step process, mentioned
above, per FASB ASC Topic 606 to recognize sales and will follow that directive, also, to define revenue items as individual and distinct.
INTRUSION Shield services provided to its customers for a fixed monthly subscription fee include:
|
· |
Access to Intrusion’s proprietary software and database to detect and prevent unauthorized access to its clients’ information networks; |
|
· |
Use of all software, associated media, printed materials, data, files, online documentation, and any equipment that Intrusion provides for customers to access the INTRUSION Shield; and |
|
· |
Tech support, post contract customer support (PCS) includes daily program releases or corrections provided by Intrusion without additional charge. |
INTRUSION Shield contracts provide
for no other services, and the Company’s customers have no rebates or return rights, nor are any such rights anticipated to be offered
as part of this service.
The Company satisfies its performance obligation
when its INTRUSION Shield solution is available to detect and prevent unauthorized access to a client’s information
networks. Revenue is recognized monthly over the term of the contract. The Company’s standard initial contract terms automatically
renew unless notice is given 30 days before renewal. Upfront payment of fees is deferred and amortized into income over the period covered
by the contract.
The Company’s accounts receivable represents
unconditional contract billings for sales per contracts with customers and are classified as current assets. As of December 31, 2022,
and 2021, the Company had accounts receivable balance of $0.5 and $1.0 million, respectively. The Company did not recognize an allowance
for doubtful accounts as of December 31, 2022, and 2021.
The Company classifies its contract assets as
receivables because the Company generally has an unconditional right to payment for its sales or services performed at the end of the
reporting period. As a result, the Company had no material contract assets as of December 31, 2022, and 2021.
Contract liabilities consist of cash payments
in advance of the Company satisfying performance obligations and recognizing revenue. The Company currently classifies contract liabilities
as deferred revenue.
The following table presents changes in the Company’s
contract liability during the years ended December 31, 2022, and 2021 (in thousands):
Schedule of contract liabilities | |
| | |
| |
| |
December 31, 2022 | | |
December 31, 2021 | |
Balance at beginning of year | |
$ | 560 | | |
$ | 177 | |
Additions | |
| 1,877 | | |
| 1,953 | |
Revenue recognized | |
| (1,982 | ) | |
| (1,570 | ) |
Balance at end of year | |
$ | 455 | | |
$ | 560 | |
Accounting for Stock-based Compensation
Awards
The Company accounts for share-based compensation
awards using the guidance in FASB ASC Topic 718, Compensation-Stock Compensation (“ASC 718”). The Company’s share-based
compensations awards are awarded to directors, officers, and employees. ASC 718 requires all such share-based payments, including grants
of employee stock options, to be recognized in the financial statements based on their fair values. Share-based compensation expense recognized
in the statements of operations for the years ended 2022 and 2021 is based on awards ultimately expected to vest.
Research and Development Costs
The Company’s research and development of
new software products are expensed until the application development stage is obtained. Once the application development stage is reached,
internal and external costs are capitalized until the software is complete and ready for its intended use. The company incurs research
and development costs that relate primarily to the development of new security software, appliances and integrated solutions, and major
enhancements to existing services and products. Research and development costs are comprised primarily of sales and related benefit expenses,
contract labor and prototype and other expenses incurred during research and development efforts.
Pursuant to ASC Topic 350-40 Internal Use Software
Accounting-Capitalization, software development costs related to the Company’s products during the application development stage
are capitalized.
Advertising Expenses
The cost of advertising is expensed as incurred
or deferred until first use of advertising and expensed ratably over the applicable periods. Advertising expense was $0.5 million and
$1.3 million for 2022 and 2021, respectively.
Income Taxes
Deferred income taxes are determined using the
liability method in accordance with FASB ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities are recognized
for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In addition, a valuation
allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than not that some portion
of the deferred tax asset will not be realized.
FASB ASC 740 creates a single model to address
accounting for uncertainty in tax positions by prescribing a minimum recognition threshold that a tax position is required to meet before
being recognized in the financial statements. FASB ASC 740 also provides guidance on derecognition, measurement, classification, interest
and penalties, accounting in interim periods, disclosure, and transition. There are no unrecognized tax benefits to disclose in the notes
to the consolidated financial statements.
The Company files income tax returns in the U.S.
federal jurisdiction. On December 31, 2022, tax returns related to fiscal years ended December 31, 2019 through December 31,
2021 remain open to possible examination by most tax authorities while tax returns in a few states remaining open related to fiscal years
ended December 31, 2018 through December 31, 2021. No tax returns are currently under examination by any tax authorities.
Net Loss Per Share
The Company reports two separate net loss per
shares numbers, basic and diluted. Basic net loss attributable to common stockholders per share is computed by dividing net loss attributable
to common stockholders for the year by the weighted average number of common shares outstanding for the year. Diluted net loss attributable
to common stockholders per share is computed by dividing the net loss attributable to common stockholders for the year by the weighted
average number of common shares and dilutive common stock equivalents outstanding for the year. The common stock equivalents include all
common stock issuable upon the exercise of outstanding options and vesting of restricted stock awards. The aggregate number of common
stock equivalents excluded from the diluted loss per share calculated for the year ended December 31, 2022 totaled 1,317,973 and 901,388,
respectively. Since the Company is in a net loss position for the year ended December 31, 2022, and 2021, basic and dilutive net loss
per share is the same.
Recent Accounting Pronouncements
None.
3. Prepaid Expenses and Other Assets
Prepaid expenses and other assets included the following (dollars in
thousands):
Schedule of prepaid expenses | |
| | |
| |
| |
December 31, | |
| |
2022 | | |
2021 | |
| |
| | |
| |
Prepaid insurance | |
$ | 107 | | |
$ | 105 | |
Prepaid licenses | |
| 98 | | |
| 80 | |
Employee retention credit receivable | |
| 1,363 | | |
| – | |
Prepaid other | |
| 309 | | |
| 171 | |
Total prepaid expenses and other assets | |
$ | 1,877 | | |
$ | 356 | |
4. Accrued Expenses
Accrued expenses consisted of the following (dollars in thousands):
Schedule of accrued liabilities | |
| | |
| |
| |
December 31, | |
| |
2022 | | |
2021 | |
| |
| | |
| |
Accrued legal and professional fees | |
$ | 189 | | |
$ | 254 | |
Accrued payroll | |
| 195 | | |
| 211 | |
Employee benefits payable | |
| 36 | | |
| 22 | |
Other | |
| 26 | | |
| 47 | |
Total accrued expenses | |
$ | 446 | | |
$ | 534 | |
5. Right-of-use Asset and Leasing Liabilities
The Company has operating, and finance leases
and records right-of-use assets and related lease liabilities as required under ASC 842. The lease liabilities are determined by the net
present value of total lease payments and amortized over the life of the lease. All obligations under the Company’s lease agreements
are designed to terminate with the last scheduled payment. The Company leases are for the following types of assets:
|
· |
Computer hardware and copy machines – The Company’s finance lease right-of-use assets consist of computer hardware and copy machines. These leases have a three-year life and are in various stages of completion. |
|
|
|
|
· |
Office space – The Company’s operating lease right-of-use assets include rental agreements for its offices in Plano, TX and a data service center in Allen, TX. The Plano offices operating lease liability was modified during the year ended December 31, 2021, to add an additional floor of office space and terminate the prior lease. The modified lease has a life of ten months as of December 31, 2022. The data service center operating lease liability has a life of two years and ten months as of December 31, 2022. |
Lease balances are recorded on the consolidated balance sheet as
follows (in thousands):
Schedule of lease information | |
| | |
| |
| |
December 31, | |
| |
2022 | | |
2021 | |
Assets: | |
| | |
| |
Finance leases, right-of-use assets, net | |
$ | 1,048 | | |
$ | 1,709 | |
Operating leases, right-of-use assets, net | |
| 504 | | |
| 808 | |
Total lease assets | |
| 1,552 | | |
| 2,517 | |
Liabilities: | |
| | | |
| | |
Current: | |
| | | |
| | |
Finance leases liabilities, current portion | |
| 667 | | |
| 644 | |
Operating leases liabilities, current portion | |
| 294 | | |
| 935 | |
Non-current: | |
| | | |
| | |
Finance leases liability, noncurrent portion | |
| 10 | | |
| 673 | |
Operating lease liability, noncurrent portion | |
| 231 | | |
| 1,250 | |
Total lease liabilities | |
$ | 1,202 | | |
$ | 3,502 | |
| |
| | | |
| | |
Weighted average remaining lease term – Finance leases | |
| 1.58 years | | |
| 2.66 years | |
Weighted average remaining lease term – Operating leases | |
| 2.20 years | | |
| 2.94 years | |
Weighted average discount rate – Finance leases | |
| 3.37% | | |
| 3.35% | |
Weighted average discount rate – Operating leases | |
| 3.42% | | |
| 4.70% | |
As the implicit rate is not readily determinable
for the Company's lease agreement, the Company uses an estimated incremental borrowing rate to determine the initial present value of
lease payments. This discount rate for the lease approximates federal reserves’ prime rate.
The gross amount of assets recorded under finance
leases was $3.2 million as of the years ended December 31, 2022, and 2021.
Certain of the Company’s lease agreements
have options to extend the lease after the expiration of the initial term. The Company recognizes the cost of a lease over the expected
total term of the lease, including optional renewal periods that the Company can reasonably expect to exercise. The Company does not have
material obligations whereby the Company guarantees a residual value on assets the Company leases, nor do the Company’s lease agreements
impose restrictions or covenants that could affect its ability to make distributions.
Schedule of Items Appearing on the Statement of Operations
(in thousands):
Lease cost table | |
| | |
| |
| |
Year Ended | |
| |
December 30, 2022 | | |
December 31, 2021 | |
Operating expense: | |
| | | |
| | |
Amortization expense – Finance ROU | |
$ | 665 | | |
$ | 306 | |
Lease expense – Operating ROU | |
| 304 | | |
| 341 | |
Other expense: | |
| | | |
| | |
Interest expense – Finance ROU | |
| 35 | | |
| 20 | |
Total Lease Expense | |
$ | 1,004 | | |
$ | 667 | |
Other supplemental information related to the Company’s leases
are as follows:
Schedule of other supplemental information related to our leases | |
| | |
| |
| |
Year Ended | |
| |
December 30, 2022 | | |
December 31, 2021 | |
Cash paid for amounts included in the measurement of lease liabilities: | |
| | |
| |
Operating cash flows for operating leases | |
$ | (1,085 | ) | |
$ | 33 | |
Operating cash flows for finance leases | |
| 665 | | |
| 306 | |
Financing cash flows for finance leases | |
| (645 | ) | |
| (699 | ) |
Future minimum lease obligations consisted of the following as of
December 31, 2022 (in thousands):
Future minimum lease obligations | |
| | |
| | |
| |
| |
Operating | | |
Finance | | |
| |
Year ending December 31, | |
ROU Leases | | |
ROU Leases | | |
Total | |
2023 | |
$ | 307 | | |
$ | 680 | | |
$ | 987 | |
2024 | |
| 123 | | |
| 8 | | |
| 131 | |
2025 | |
| 115 | | |
| 3 | | |
| 118 | |
| |
$ | 545 | | |
$ | 691 | | |
$ | 1,236 | |
Less Interest* | |
| (20 | ) | |
| (14 | ) | |
| | |
| |
$ | 525 | | |
$ | 677 | | |
| | |
* |
Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying consolidated statements of operations. |
On March 10, 2022, Intrusion Inc. entered into
an unsecured loan agreement with Streeterville Capital, LLC whereby the Company could draw up to $10.0 million in two separate tranches
of $5.0 million through the issuance of two separate promissory notes of $5.4 million each, with an initial interest rate of 7%, subject
to some increases in the case of, among other things, an event of default. On March 10, 2022, the Company received $4.6 million in net
funds from the first tranche (First Note) pursuant to a promissory note executed contemporaneously with the execution of the loan agreement.
On June 29, 2022, the Company received an additional $4.7 million in net funds from the second tranche (Second Note) pursuant to a promissory
note. Each note has an 18-month maturity, may be prepaid subject to varying prepayment premiums, and may be redeemed at any time after
six months into the term of such note in amounts up to $0.5 million per calendar month upon the noteholder’s election. The Company
has the option, in its sole discretion, to satisfy any redemption demands in cash or shares of its common stock that will be issued in
an amount equal to the dollar amount of the redemption demand divided by the number that represents 85% of the average of the two lowest
daily volume weighted average prices of common stock over a fifteen-day trailing period. This option to settle in shares at an 15% discount
is deemed a beneficial conversion feature (“BCF”).
The loan agreement and accompanying notes are
subject to standard and customary events of default, including, without limitation, the Company’s continued listing on the Nasdaq
or New York Stock Exchange. While the notes remain outstanding, the Company will be subject to certain conditions and restrictions, including,
without limitation the following: the noteholder’s right to consent to any future variable rate transactions (excluding ATMs, equity
offerings, or private placements without market adjustable features) and any debt (excluding bank loans, lines of credit, mortgagees,
leases, or asset backed loans); the noteholder’s right to participate in any debt or equity financings, excluding (ATMs, loans,
lines of credit, mortgagees, leases, or asset backed loans); a prohibition on the Company’s ability to extend or enter into any
agreement restricting its ability to issue common stock under the notes; as well as a prohibition on its ability to permit any other lender
to participate alongside the noteholder via any debt financing structures.
The Company evaluated both the First and Second
Note in accordance with ASC 480 “Distinguishing Liabilities from Equity” because the promissory note (1) embodies an
option redemption obligation, (2) may require the Company to settle the optional redemption obligation by issuing a variable number of
its common shares, and (3) is based solely on a fixed monetary amount known at inception.
The lender does not benefit if the fair value
of the Company’s Common Stock increases and does not bear the risk that the fair value of the Company’s Common Stock might
decrease. In accordance with ASC 480, the promissory notes have been recorded as a liability and the company is recording interest expense
over the term of the promissory note, using the interest method from ASC 835-30, to accrete the carrying amount of the promissory note
up to the redemption common stock settlement amount.
On March 10, 2022, the Company recorded debt
issue costs of $0.7 million as an offset to the promissory note to be amortized over the 18-month term associated with the First Note.
On June 29, 2022, the Company recorded debt issue costs of $0.7 million as an offset to the promissory note to be amortized over the
18-month term associated with the Second Note. As of December 31, 2022, the balance of unamortized debt issuance costs for both notes
were $0.5 million. For the year ended December 31, 2022, the Company recorded $0.9 million for amortization of the debt
discounts related to both notes to interest expense in the accompanying Consolidated Statement of Operations. The effective interest
rate of the notes payable including amortization of the debt issuance costs and accretion of BCF is 35.19%.
For the year ended December 31, 2022,
the Company recorded $1.5 million of interest expense in the accompanying Consolidated Statement of Operations. The interest recorded
associated with the unsecured promissory notes increases the associated notes payable on the accompanying Consolidated Balance Sheet.
The balances on the notes payable mature in September and December 2023.
On January 11, 2023, the Company amended the promissory
notes issued pursuant to the unsecured loan agreement with Streeterville Capital, LLC whereby the noteholder agreed to waive their redemption
rights through March 31, 2023, in exchange for a fee equal to 3.75% of the outstanding principal balance which was added to the outstanding
indebtedness.
7. Commitments and Contingencies
Change of Control and Severance Agreements
Certain members of the Company’s management
are parties to severance and change of control agreements with the Company. The severance and change in control agreements provide those
individuals with severance payments in certain circumstances and prohibit such individuals from, among other things, competing with the
Company during his or her employment. In addition, the severance and change of control agreements prohibit subject individuals from, among
other things, disclosing confidential information about the Company and its products or interfering with a client or customer of the Company,
in each case during his or her employment and for certain periods (including indefinite periods) following the termination of such person’s
employment.
Legal Proceedings
The Company is periodically involved in various
litigation claims arising in the normal course of business. The Company believes these actions are routine and incidental to the business.
While the outcome of these actions cannot be predicted with certainty, the Company does not believe that any will have a material adverse
impact on the Company’s business.
Class Action Litigation
On April 16, 2021, a class action lawsuit was
filed in the United States District Court, Eastern District of Texas, Sherman Division, captioned Celeste v. Intrusion Inc. et al., Case
No. 4:21-cv-00307 (E.D. Tex.) against the Company, the Company’s now-former chief financial officer, and now-former chief executive
officer alleging, among other things, that the defendants made false and/or misleading statements or omissions about the Company’s
business, operations, and prospects in violation of Section 10(b) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and Rule 10b-5 promulgated thereunder, as well as Section 20(a) of the Exchange Act. The Celeste lawsuit claimed compensatory
damages and legal fees.
On May 14, 2021, a related class action lawsuit
was filed in the United States District Court, Eastern District of Texas, Sherman Division, captioned Neely v. Intrusion Inc., et al.,
Case No. 4:12-cv-00374 (E.D. Tex.) against the Company, the Company’s now-former chief financial officer, and now-former chief executive
officer. The Neely lawsuit alleged the same violations under the federal securities laws as those alleged in the Celeste lawsuit. The
Neely lawsuit also sought compensatory damages and legal fees.
On November 23, 2021, the Court consolidated the
Celeste and Neely actions, and appointed a lead plaintiff and lead plaintiff’s counsel. The lead plaintiff filed his amended complaint
on February 7, 2022. The amended complaint named the following additional parties as named defendants: Mr. Michael Paxton, a former director
and executive officer; Mr. Gary Davis, a former officer; Mr. Joe Head, the current chief technology officer, and a former director; and
Mr. James Gero, a current director and chair of the compensation committee.
The parties to the consolidated action held
a mediation on April 5, 2022, at the conclusion of which the parties executed a settlement term sheet setting forth the material
terms associated with the resolution of the action, subject to the preparation of formal documents and a plan of distribution
approved by the Court. The settlement agreement was subject to certain terms and conditions and received final approval by the Court
on December 16, 2022. At that time, a final judgment was entered dismissing the case, with the Court retaining jurisdiction over the
action for purposes of enforcing the terms of the class settlement agreement. The $3.3
million settlement was paid by the Company’s insurance provider under its insurance policy as the Company’s
retention had previously been exhausted.
The lead plaintiff in the class action filed a
motion for distribution of settlement funds on February 21, 2023. The Court approved the parties’ class action settlement and plan
of allocation on March 22, 2023 and cancelled the previously-rescheduled March 31, 2023, hearing on the motion for distribution, all remaining
matters in the class action then-pending having been fully and finally adjudicated.
Securities Investigation
On August 8, 2021, the Company received a notification
from the Securities and Exchange Commission, Division of Enforcement, that it was investigating captioned In the Matter of Intrusion Inc.
and requesting the Company produce certain documents and information. On November 9, 2021, the Securities and Exchange Commission served
a subpoena to the Company in connection with this investigation which formally requested substantially similar information as in the prior
request. The Company is continuing to comply with the requests and are cooperating in the investigation. The Company can offer no assurances
as to the outcome of this investigation or its potential effect on the Company or its results of operations.
Stockholder Derivative Claim
On June 3, 2022, a verified stockholder derivative
complaint was filed in U.S. District Court, District of Delaware by plaintiff Nathan Prawitt (the “Plaintiff Stockholder”)
on behalf of Intrusion against certain of the Company’s current and former officers and directors (the “Defendants”).
Plaintiff alleges that Defendants through various actions breached their fiduciary duties, wasted corporate assets, and unjustly enriched
Defendants by (a) incurring costs and expenses in connection with the ongoing SEC investigation, (b) incurring costs and expenses to defend
the Company with respect to the consolidated class action, (c) settling class-wide liability with respect to the consolidated class action,
as well as ancillary claims regarding sales of the Company’s common stock by certain of the Defendants. The Plaintiff is seeking
remedial actions including improvements in the Company’s corporate governance and internal control policies and reimbursement of
legal costs. While the Company is not a named defendant, but a nominal plaintiff in the stockholder derivative claim, the Company will
be providing the financial and other assistance for each of the Defendants that the Company is obligated to provide under the Company’s
Articles of Incorporation, the Company’s Bylaws, as well as individual indemnifications agreements that are in effect between, the
Company and each of the Defendants.
In addition to these legal proceedings, the Company
is subject to various other claims that may arise in the ordinary course of business. The Company does not believe that any claims exist
where the outcome of such matters would have a material adverse effect on the Company’s condensed consolidated financial position,
operating results, or cash flows. However, there can be no assurance such legal proceedings will not have a material impact on the Company’s
future results.
8. Common Stock
ATM Offering
In August of 2021, the Company engaged B. Riley
Securities, Inc. to act as sales agent under the Company’s at-the-market program, which allows us to potentially sell up to $50.0
million of its common stock on a delayed or continuous basis using a shelf registration statement on Form S-3, which the Company initially
filed on August 5, 2021. The shelf registration became effective on August 16, 2021. For the year ended December 31, 2022, the Company
has received proceeds of approximately $2.0 million net of fees from the sale of common stock pursuant to the program. Since the program
was initiated, the Company has received proceeds of approximately $7.5 million net of fees from the sales of 1,843 thousand shares of
common stock pursuant to the program.
Registered Direct Offering
On September 12, 2022, the Company entered in
a Securities Purchase Agreement (the “Purchase Agreement”) with certain purchasers to issue and sell to the purchasers an
aggregate of 1,378,677 shares of the Company’s common stock (the “Shares”) each of which was coupled with a warrant
to purchase one share of common stock (the “Warrants”) at an aggregate offering price of $4.29 per share and warrant, such
offering is hereinafter referred to as its “registered direct offering”. Each warrant has an exercise price of $5.22 per share
of common stock, subject to adjustment for stock splits, reverse stock splits, stock dividends and similar transactions and is exercisable
from the date of its issuance through September 14, 2027. The Company delivered 939,284 Shares and Warrants on or about September 14,
2022. After September 30, 2022, the company issued an additional 273,309 Shares and related Warrants as a result of delayed closings.
On November 10, 2022, the Company, reached an agreement with the sole remaining delayed basis investor in the registered direct offering
to reduce the purchaser’s subscription by $0.7 million and, accordingly, reduce the Company’s obligation to issue securities.
Following the final closing, the Company had received from its registered direct offering total aggregate proceeds of $5.2 million in
exchange for the issuance of an aggregate of 1,212,593 shares of common stock and warrants to purchase 1,212,593 shares of common stock.
9. Stock-Based Compensation
The Company accounts for equity-based compensation
in accordance with ASC 718, Compensation – Stock Compensation, which requires that compensation related to all equity-based
awards be recognized in the consolidated financial statements. Equity-based compensation cost is valued at fair value at the date of grant,
and the grant date fair value is recognized as expense over each award’s requisite service period with a corresponding increase
to equity or liability based on the terms of each award and the appropriate accounting treatment under ASC 718.
The Company had three stock-based compensation
plans on December 31, 2022, and 2021. These plans which are described below, were developed to retain, and attract key employees and directors.
The 2021 Omnibus Incentive Plan (the “2021
Plan”)
During 2021, the Company added a new incentive
2021 Omnibus Incentive Plan. The purpose of the 2021 Plan is to provide a means through which the Company may attract and retain key personnel
and to provide a means whereby directors, officers, employees, consultants and advisors of the Company can acquire and maintain an equity
interest in the Company, or be paid incentive compensation, including incentive compensation measured by reference to the value of common
stock, thereby strengthening their commitment to the welfare of the Company and aligning their interests with those of the Company’s
stockholders.
The 2021 Plan is administered by the Compensation
Committee of the Company’s Board of Directors and permits the grant of cash and equity-based awards, which may be awarded in the
form of stock options, stock appreciation rights, restricted stock awards, performance awards, other stock-based awards, and other cash-based
awards.
The aggregate number of shares of Common Stock
that may be issued or used for reference purposes or with respect to which Awards may be granted under the 2021 Plan shall not exceed
2,500,000 shares and is subject to any increase or decrease, which shares may be either authorized and unissued Common Stock or Common
Stock held in or acquired for the treasury of the Company or both.
The 2015 Stock Incentive Plan (“the
“2015 Plan”)
On March 19, 2015, the Board approved the
2015 Stock Incentive Plan (the “2015 Plan”), which was approved by the stockholders on May 14, 2015. The 2015 Plan serves
as a replacement for the 2005 Plan which expired by its terms on June 14, 2015. The approval of the 2015 Plan had no effect on the
2005 Plan or any options granted pursuant to the plan. All options will continue with their existing terms and will be subject to the
2005 Plan. Further, the Company will not be able to re-issue any option which is cancelled or terminated under the 2005 Plan. The 2015
Plan provided for the issuance of up to 600,000 shares of common stock upon exercise of options granted pursuant to the 2015 Plan.
The 2015 Plan consists of three separate equity
incentive programs: the Discretionary Option Grant Program; the Stock Issuance Program; and the Automatic Option Grant Program for non-employee
Board members. Officers and employees, non-employee Board members and independent contractors are eligible to participate in the Discretionary
Option Grant and Stock Issuance Programs. Participation in the Automatic Option Grant Program is limited to non-employee members of the
Board. Each non-employee Board member will receive an option grant for 10,000 shares of common stock upon initial election or appointment
to the Board, provided that such individual has not previously been employed by the Company in the preceding three (3) months. In
addition, on the date of each annual stockholders’ meeting, each Board member will automatically be granted an option to purchase
10,000 shares of common stock, provided he or she has served as a non-employee Board member for at least three months.
During the year ended December 31, 2021, the Board
of Directors (“Board”) approved a new clause to the 2015 Plan, to accelerate the vesting of any unvested equity grants held
by outside directors upon their retirement from the Board. Pursuant to the approval of the acceleration clause, during the second quarter
of 2021, the equity awards held by two outside board members who retired from the Board in May 2021 became fully vested. The Company accounts
for the acceleration of the related stock options as a modification of the option award under ASC 718. Accordingly, the Company recognized
incremental stock compensation expense of approximately $0.2 million during the year ended December 31, 2021.
The 2005 Stock Incentive Plan (the “2005
Plan”)
On March 17, 2005, the Board approved the
2005 Stock Incentive Plan (the “2005 Plan”), which was approved by the stockholders on June 14, 2005. The 2005 Plan provided
for the issuance of up to 750,000 shares of common stock upon exercise of options granted pursuant to the 2005 Plan. On May 30, 2007,
the stockholders approved an Amendment to the 2005 Plan that increased this amount by 750,000 for a total of 1,500,000 shares of common
stock that may be issued upon the exercise of options granted pursuant to the 2005 Plan. On May 29, 2008, and May 21, 2009,
the stockholders approved an increase of 500,000 shares, respectively, of common stock that may be issued pursuant to the 2005 Plan for
a total of 2,500,000 shares. On May 20, 2010, the stockholders approved an additional increase of 500,000 shares of common stock
that may be issued pursuant to the 2005 Plan for a total of 3,000,000 shares. On May 19, 2011, the stockholders approved an additional
increase of 400,000 shares of common stock that may be issued pursuant to the 2005 Plan for a total of 3,400,000 shares. Finally, on May 17,
2012, the stockholders approved an additional increase of 300,000 shares of common stock that may be issued pursuant to the 2005 Plan
for a total of 3,700,000 shares.
The Compensation Committee of the Company’s
Board of Directors determines for all employee options, the term of each option, option exercise price within limits set forth in the
plans, number of shares for which each option is granted and the rate at which each option is exercisable (generally ratably over one,
three or five years from grant date). However, the exercise price of any stock option may not be less than the fair market value of the
shares on the date granted (or less than 110% of the fair market value in the case of optionees holding more than 10% of its voting stock
of the Company), and the term cannot exceed ten years (five years for incentive stock options granted to holders of more than 10% of the
Company’s voting stock).
Common shares reserved for future issuance, including
outstanding options, unvested restricted stock and shares available for future grant under all the stock options plans are as follows:
Schedule of common shares reserved for future issuance | |
| | |
(In thousands) | |
Common Shares Reserved for Future Issuance | |
| |
| |
2021 Plan | |
| 2,403 | |
2015 Plan | |
| 530 | |
2005 Plan | |
| 162 | |
Total | |
| 3,095 | |
Total compensation expense in operating expense
on the statement of operations of $1.5 and $1.3 million during the years ended December 31, 2022, and 2021, respectively.
Restricted Stock Awards
During the year ended December 31, 2022, the
Company issued new Restricted Stock Awards (RSAs) under the 2021 Plan in the amount of $0.4
million in value of restricted stock to each of the Company’s outside directors and certain members of management, with
a valuation to be based on the closing price of the Company’s common stock on the Nasdaq Capital Market. Accordingly, 131,580
shares were granted and are expected to fully vest in one year on the anniversary of the grant date.
The following table summarizes the activities for the Company’s
unvested RSAs in Intrusion Inc. stock for the year ended December 31, 2022:
Schedule of unvested RSAs | |
| | |
| |
| |
| Unvested Restricted Stock Awards | |
| |
| Number of Shares (in thousands) | | |
| Weighted-Average Grant-Date Fair Value | |
Unvested as of December 31, 2021 | |
| 149 | | |
$ | 5.54 | |
Granted | |
| 132 | | |
| 2.66 | |
Vested | |
| (97 | ) | |
| 6.41 | |
Forfeited/canceled | |
| (26 | ) | |
| 3.85 | |
Unvested as of December 31, 2022 | |
| 158 | | |
$ | 2.88 | |
The Company recognized compensation expense related
to its RSAs of $0.6 million during the year ended December 31, 2022. As of December 31, 2022, there was $0.2 million of unrecognized compensation
cost related to unvested RSAs. This amount is expected to be recognized over a weighted-average period of 0.7 years.
Stock Option Awards
The Company also granted option awards under the
2015 Plan to its employees with the option price for each option set at the closing price for the Company’s Common Stock on the
Nasdaq Capital Market on the grant date during the year ended December 31, 2022.
A summary of the Company’s stock option activity and related
information for the years ended December 31, 2022, and 2021 is as follows:
Schedule of option activities | |
| | |
| | |
| | |
| |
| |
2022 | | |
2021 | |
| |
Number of Options (in thousands) | | |
Weighted Average Exercise Price | | |
Number of Options (in thousands) | | |
Weighted Average Exercise Price | |
| |
| | |
| | |
| | |
| |
Outstanding at beginning of year | |
| 617 | | |
$ | 6.47 | | |
| 1,035 | | |
$ | 2.87 | |
Granted | |
| 334 | | |
| 3.63 | | |
| 606 | | |
| 12.99 | |
Exercised | |
| (99 | ) | |
| 0.67 | | |
| (257 | ) | |
| 0.97 | |
Forfeited | |
| (156 | ) | |
| 8.16 | | |
| (634 | ) | |
| 9.81 | |
Expired | |
| (28 | ) | |
| 13.47 | | |
| (133 | ) | |
| 2.82 | |
Outstanding at end of year | |
| 668 | | |
$ | 5.22 | | |
| 617 | | |
$ | 6.47 | |
Options exercisable at end of year | |
| 281 | | |
$ | 4.13 | | |
| 317 | | |
$ | 1.56 | |
Information related to stock options outstanding on December 31,
2022, is summarized below:
Schedule of stock options by exercise price | |
| | |
| | |
| | |
| | |
| |
| |
| Options Outstanding | | |
| Options Exercisable | |
Range of Exercise Prices | |
| Outstanding at 12/31/21 (in thousands) | | |
| Weighted Average Remaining Contractual Life (years) | | |
| Weighted Average Exercise Price | | |
| Exercisable at 12/31/21 (in thousands) | | |
| Weighted Average Exercise Price | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
$0.40 - $0.48 | |
| 88 | | |
| 0.81 | | |
$ | .47 | | |
| 88 | | |
$ | .47 | |
$1.15 - $2.80 | |
| 98 | | |
| 1.57 | | |
$ | 1.78 | | |
| 98 | | |
$ | 1.78 | |
$3.45 - $4.75 | |
| 331 | | |
| 9.17 | | |
$ | 3.72 | | |
| 35 | | |
$ | 4.38 | |
$8.72 - $12.71 | |
| 135 | | |
| 8.27 | | |
$ | 12.21 | | |
| 53 | | |
$ | 11.87 | |
$23.52 - $23.52 | |
| 17 | | |
| 8.17 | | |
$ | 23.52 | | |
| 7 | | |
$ | 23.52 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
$0.40 - $23.52 (all) | |
| 668 | | |
| 6.73 | | |
$ | 5.22 | | |
| 281 | | |
$ | 4.13 | |
Summarized information about outstanding stock options as of December 31,
2022, that are expected to vest in the future as well as stock options that are fully vested and currently exercisable, are as follows:
Other information regarding stock options | |
| | |
| |
| |
Outstanding Stock Options (Expected to Vest) | | |
Options that are Exercisable | |
As of December 31, 2022 | |
| | | |
| | |
Number of outstanding options (in thousands) | |
| 688 | | |
| 281 | |
Weighted average remaining contractual life | |
| 6.73 years | | |
| 3.39 years | |
Weighted average exercise price per share | |
$ | 5.22 | | |
$ | 4.13 | |
Intrinsic value (in thousands) | |
$ | 372 | | |
$ | 372 | |
The fair values of option awards were estimated at the date of grant
using a Black-Scholes option-pricing model with the following assumptions for fiscal years ended December 31, 2022, and 2021, respectively:
Valuation assumptions for stock-based compensation | |
| | |
| |
| |
2022 | | |
2021 | |
| |
| | |
| |
Weighted average grant date fair value | |
$ | 3.32 | | |
$ | 8.09 | |
Weighted average assumptions used: | |
| | | |
| | |
Expected dividend yield | |
| 0.00% | | |
| 0.00% | |
Risk-free interest rate | |
| 2.17% | | |
| 0.70% | |
Expected volatility | |
| 129.54% | | |
| 66.72% | |
Expected life (in years) | |
| 6.76 | | |
| 4.29 | |
Expected volatility is based on historical volatility
and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture
behavior. The risk-free interest rate is based on the rates in effect on the grant date for U.S. Treasury instruments with maturities
matching the relevant expected term of the award.
The Company recognized compensation expense related
to its stock options of $0.9 million during the year ended December 31, 2022. As of December 31, 2022, the total unrecognized compensation
cost related to non-vested options not yet recognized in the statement of operations totaled approximately $0.8 million and the weighted
average period over which these awards are expected to vest was 2.12 years.
10. Employee Benefit Plan
Employee 401(k) Plan
The Company has a plan known as the
Intrusion Inc. 401(k) Savings Plan (the “Plan”) to provide retirement and incidental benefits for the
Company’s employees. The Plan covers substantially all employees who meet minimum age and service requirements. As allowed
under Section 401(k) of the Internal Revenue Code (“IRS”), the Plan provides tax deferred salary deductions
for eligible employees.
Employees may contribute the lesser of 1% to 90%
of their annual compensation to the Plan, limited to a maximum amount as set by the IRS. Participants who are over the age of 50 may contribute
an additional amount of their salary per year, as defined annually by the IRS. The Company matches employee contributions at the rate
of 0.25% per each 1% of contribution on the first 4% of compensation. Matching contributions to the Plan were approximately $0.1 million
each for the years ended December 31, 2022, and 2021.
11. Related Party Transactions
During 2022, the Company retained legal services
of a third-party law firm for which the Company’s Chief Executive Officer is a senior advisor. The Company recognized $0.3 and $0.0
million for the years ended December 31, 2022 and 2021 respectively in general and administrative expense on the Consolidated Statements
of Operations. On December 31, 2022 and 2021, $0.1 and $0.0 million payable to the third-party law firm was included in accounts payable,
trade on the Consolidated Balance Sheets. The rates paid for legal services to the third-party firm were comparable to rates paid to other
law firms providing legal services to the Company.
12. Income Taxes
Deferred income taxes reflect the net tax effects
of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used
for income tax purposes. Significant components of the Company’s deferred tax assets (liabilities) as of December 31, 2022,
and 2021 are as follows (in thousands):
Schedule of deferred tax assets and liabilities | |
| | |
| |
| |
December 31 | |
| |
2022 | | |
2021 | |
| |
| | |
| |
Net operating loss carryforwards | |
$ | 15,994 | | |
$ | 22,497 | |
Net operating loss carryforwards of foreign subsidiaries | |
| 56 | | |
| 56 | |
Depreciation expense | |
| (73 | ) | |
| (94 | ) |
Stock-based compensation expense | |
| 349 | | |
| 52 | |
Other | |
| 830 | | |
| 544 | |
Net deferred tax assets | |
| 17,156 | | |
| 23,055 | |
Valuation allowance for net deferred tax assets | |
| (17,156 | ) | |
| (23,055 | ) |
Net deferred tax assets, net of allowance | |
$ | – | | |
$ | – | |
Deferred tax assets are required to be reduced
by a valuation allowance if it is more likely than not that some portion or all the deferred tax assets will not be realized. Realization
of the future benefits related to the deferred tax assets is dependent on many factors, including the Company’s ability to generate
taxable income within the near to medium term. Management has considered these factors in determining the valuation allowance for 2022
and 2021.
The differences between the provision for income
taxes and income taxes computed using the federal statutory rate for the years ended December 31, 2022, and 2021 are as follows (in
thousands):
Schedule of effective income tax rate reconciliation | |
| | |
| |
| |
2022 | | |
2021 | |
| |
| | |
| |
Reconciliation of income tax benefit to statutory rate: | |
| | | |
| | |
Income benefit at statutory rate | |
$ | (3,409 | ) | |
$ | (3,948 | ) |
State income taxes (benefit), net of federal income tax benefit | |
| (107 | ) | |
| (331 | ) |
Permanent differences | |
| 89 | | |
| (206 | ) |
Change in valuation allowance | |
| (5,899 | ) | |
| 2,458 | |
Expiring federal net operating losses | |
| 9,745 | | |
| – | |
Other | |
| (419 | ) | |
| 2,027 | |
Income tax provision | |
$ | – | | |
$ | – | |
On December 31, 2022, the Company had federal
net operating loss carryforwards of approximately $76.1 million for income tax purposes that begin to expire in 2022 and are subject to
the ownership change limitations under Internal Revenue Code Section 382.
13. Cares Act Employee Retention Credit Receivable and SBA
Paycheck Protection Program Loan
Interest and other income include $2.0 million,
net of fees resulting from ERC claimed on amended IRS quarterly federal tax returns (“941s”) filed during the third quarter.
The ERC was established by the Coronavirus Aid, Relief and Economic Security Act (“Cares Act”). The Cares Act allows relief
to business affected by the coronavirus pandemic, by providing payments to employers for qualified wages. The Company amended 941s for
the periods from April 1, 2020, to September 31, 2021. On December 31, 2022, the Company had $1.4 million in receivables remaining outstanding
included in prepaid expenses and other assets.
On March 27, 2020, the U.S. federal government
enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), which included the provision for a PPP administered
by the U.S. Small Business Administration (“SBA”). The PPP allows qualifying businesses to borrow up to $10 million calculated
based on qualifying payroll costs. The loan was guaranteed by the federal government and did not require collateral. On April 30,
2020, the Company entered into a PPP Loan with Silicon Valley Bank, pursuant to the PPP under CARES Act for a principal amount of $0.6
million. The PPP Loan was to mature on April 30, 2022, and bear interest at a rate of 1.0% per annum. The PPP Loan funds were received
on April 30, 2020. The PPP Loan contained events of default and other provisions customary for a loan of this type. The PPP provided that
(1) the use of PPP Loan amount shall be limited to certain qualifying expenses, (2) 100% of the principal amount of the loan is guaranteed
by the SBA and (3) an amount up to the full principal amount plus accrued interest may qualify for loan forgiveness in accordance with
the terms of CARES Act.
The Company utilized the full proceeds of
the PPP Loan in accordance with the provisions of the CARES Act and submitted the PPP Loan Forgiveness Application. On April 7,
2021, the Company received notice from SBA that the PPP Loan and accrued interest was forgiven in full. As a result, the Company
recorded a gain in the extinguishment of debt of $0.6
million in interest and other income on its consolidated statements of operations during the year ended December 31, 2021.
14. Correction of Immaterial Errors
During the year ending December 31, 2022,
management identified and corrected certain immaterial errors in the Company’s historical financial statements associated with
the cost of revenues provided by a subcontractor. The errors understated the cost of revenue and overstated the sales and marketing
operating expenses by equal amounts in the Consolidated Statement of Operations. The error had no impact on operating losses, net
losses, and net loss per share nor any other financial statement amount. Further these errors had no impact on the consolidated
balance sheets, statements of changes in stockholders’ equity (deficit), and statement of cash flows. These corrections do not
affect any of the metrics used to calculate and evaluate management’s compensation and had no impact on bonuses, commissions,
stock-based compensation, or any other employee renumeration. Historical amounts have been corrected and are presented on a
comparable basis.
The below table presents the effect of the correction
for the year ended December 31, 2021:
Schedule of effect of the correction | |
| | |
| | |
| |
| |
Year Ended December 31, 2021 | |
| |
As Reported | | |
Adjustments | | |
As Corrected | |
Revenue | |
$ | 7,277 | | |
$ | – | | |
$ | 7,277 | |
Cost of Revenue | |
| 2,625 | | |
| 996 | | |
| 3,621 | |
| |
| | | |
| | | |
| | |
Gross Profit | |
| 4,652 | | |
| (996 | ) | |
| 3,656 | |
| |
| | | |
| | | |
| | |
Operating Expenses | |
| | | |
| | | |
| | |
Sales and marketing | |
| 11,931 | | |
| (996 | ) | |
| 10,935 | |
Research and development | |
| 6,328 | | |
| – | | |
| 6,328 | |
General and administrative | |
| 5,896 | | |
| – | | |
| 5,896 | |
| |
| | | |
| | | |
| | |
Operating
Loss | |
$ | (19,503 | ) | |
$ | – | | |
$ | (19,503 | ) |
15. Subsequent Events.
On January 11, 2023, the Company amended the promissory
notes issued pursuant to the unsecured loan agreement with Streeterville Capital, LLC whereby the noteholder agreed to waive their redemption
rights through March 31, 2023, in exchange for a fee equal to 3.75% of the outstanding principal balance which was added to the outstanding
indebtedness.
On February 23, 2023, the Company entered into a note purchase agreement
with Streeterville Capital, LLC (“Streeterville”), pursuant to which, among other things, Streeterville purchased from the
Company a promissory note (the “Note”) in the aggregate principal amount of $1.4 million plus certain reimbursed expenses
in exchange for $1.3 million to the Company. Under the Note, the Company shall make principal payments to Streeterville in the amount
of $50 thousand per week each week prior to its maturity on March 31, 2023. No interest accrues on the balance of the Note prior to its
maturity. In connection with the issuance of the Note, the Company and Streeterville also entered into a security agreement, which provides,
according to its term, a security interest in all employee retention credits or other funds still owed or otherwise payable to the Company
under the Cares Act. The Company received payment for the ERC owed to Intrusion on March 13, 2023, and on March 14, 2023, the Company repaid
in full and in advance of the maturity date the secured promissory note with Streeterville.